Novonix (OTCQB: NVNXF) director updates shareholding in Form 6-K

Rhea-AI Filing Summary

Novonix Limited filed a Form 6-K that includes an ASX Appendix 3Y notice showing a change in director Nicholas Liveris’s shareholding. The filing states that the change arose from an on‑market trade and that he now holds 559,090 ordinary shares as a direct interest.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2026

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No. Description

Exhibit 99.1 Appendix 3Y (Change of Director's Interest Notice) dated March 12, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED

By: /s/ Robert Long

       Robert Long

       Chief Executive Officer

Date: March 12, 2026

EXHIBIT 99.1

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NOVONIX LIMITED

ABN 54 157 690 830

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	NICHOLAS LIVERIS
Date of last notice	6 March 2026

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	10 March 2026
No. of securities held prior to change	589,142 Ordinary shares
Class	Ordinary shares
Number acquired	Nil
Number disposed	30,052 ordinary shares
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$9,194

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

EXHIBIT 99.1

Appendix 3Y

Change of Director’s Interest Notice

No. of securities held after change	559,090 Ordinary shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

EXHIBIT 99.1

Appendix 3Y Change of Director’s Interest Notice

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No.
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

FAQ

What does Novonix (NVNXF) report in its March 2026 Form 6-K?

Novonix reports a change in director Nicholas Liveris’s shareholding via an ASX Appendix 3Y. The update reflects an on-market trade and confirms his post-trade holding of 559,090 ordinary shares, held as a direct interest in the company.

Whose shareholding changed in the Novonix (NVNXF) Form 6-K filing?

The change relates to director Nicholas Liveris. The Appendix 3Y attached to the Form 6-K records an update to his relevant interest in Novonix Limited securities, following an on-market trade in the company’s ordinary shares on the ASX.

How many Novonix (NVNXF) shares does director Nicholas Liveris now hold?

After the reported change, director Nicholas Liveris holds 559,090 ordinary shares in Novonix Limited. The filing specifies that these securities are held as a direct interest, giving investors clarity on his current equity position in the company.

What type of transaction caused the director interest change at Novonix (NVNXF)?

The filing states that the director’s change in interest resulted from an on-market trade. This means the transaction occurred through normal trading on the exchange, rather than via an off-market transfer, option exercise, or other structured arrangement.

Was the Novonix (NVNXF) director trade during a closed period?

The Appendix 3Y confirms the trade was not conducted during a closed period when prior written clearance would have been required. This indicates the transaction occurred in an open trading window under the company’s share trading policy.

Does the Novonix (NVNXF) Form 6-K include contract changes for the director?

No contract changes are reported. In Part 2 of the Appendix 3Y, the section for changes in the director’s interests in contracts is marked “N/A,” indicating no relevant contracts were involved in this particular change of interest disclosure.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 61.2 KB